TORONTO and GLIL YAM, Israel,
March 23,
2022 /PRNewswire/ -- IM Cannabis Corp. (the
"Company" or "IM Cannabis") (CSE: IMCC, NASDAQ:
IMCC), a leading medical and adult-use recreational cannabis
company with operations in Israel,
Canada, and Germany, will report operational and financial
results for the fourth quarter and full year ended December 31, 2021 before market open on
Wednesday, March 30, 2022.
Management will host a conference call to discuss the results,
followed by a question-and-answer session from participants. To
participate, please use the following information:
Q4 and Full Year 2021 Conference Call
Date: Wednesday, March 30,
2022
Time: 9:00 a.m. Eastern time
(6:00 a.m. Pacific time)
U.S./Canada Dial-in: 1-877-407-9716
Israel Dial-in: 1-809-406-247
Germany Dial-in: 0-800-182-0040
International Dial-in: 1-201-493-6779
Conference ID: 13727369
Please dial in at least 10 minutes before the start of the call
to ensure timely participation.
A playback of the call will be available through Wednesday, April 27, 2022. To listen, call
1-844-512-2921 within the United
States or Canada or
1-412-317-6671 when calling internationally and enter replay pin
number 13727369. A recording of the conference call will also be
available on the events & presentations section of the IM
Cannabis investor relations website linked here.
About IM Cannabis Corp.
IM Cannabis (NASDAQ: IMCC, CSE: IMCC) is a leading international
cannabis company providing premium products to medical patients and
adult-use recreational consumers. IM Cannabis is one of the very
few companies with operations in Israel, Germany and Canada, the three largest federally legal
markets. The ecosystem created through its international operations
leverages the Company's unique data-driven perspective and product
supply chain globally. With its commitment to responsible growth
and financial prudence and ability to operate within the strictest
regulatory environments, the Company has quickly become one of the
leading cultivators and distributors of high-quality cannabis
globally.
The IM Cannabis ecosystem operates in Israel through its commercial relationship
with Focus Medical Herbs Ltd. ("Focus Medical"), which cultivates,
imports and distributes cannabis to medical patients, leveraging
years of proprietary data and patient insights. The Company also
operates medical cannabis retail pharmacies, online platforms,
distribution centres and logistical hubs through IMC Holdings in
Israel that enable the safe
delivery and quality control of IM Cannabis products throughout the
entire value chain. In Germany,
the IM Cannabis ecosystem operates through Adjupharm GmbH
("Adjupharm"), where it also distributes cannabis to
pharmacies serving medical cannabis patients. In Canada, IM Cannabis operates through Trichome
Financial Corp. and its subsidiaries, Trichome JWC Acquisition
Corp. d/b/a JWC and MYM Nutraceuticals Inc., where it cultivates
and processes cannabis for the adult-use market at its Ontario, Nova
Scotia and Quebec
facilities under the WAGNERS and Highland Grow brands.
Company Contact:
Maya Lustig, Director Investor & Public
Relations
IM Cannabis
+972-54-677-8100
maya.l@imcannabis.com
Investor Relations:
Brooks
Hamilton, Director
MZ Group – MZ North America
+1 949-546-6326
IMCC@mzgroup.us
Logo
- https://mma.prnewswire.com/media/1742228/IM_Cannabis_Logo.jpg
View original
content:https://www.prnewswire.com/news-releases/im-cannabis-to-report-fourth-quarter-and-full-year-2021-financial-results-on-wednesday-march-30-at-900-am-et-301508815.html
SOURCE IM Cannabis Corp.